| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.23 | 2e-07 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.2 | 3e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.095 | 0.05 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.066 | 0.2 |